Ecalta Special Precautions



The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Special Precautions
The efficacy of anidulafungin in neutropenic patients with candidemia and in patients with deep tissue Candida infections or intra-abdominal abscess, and peritonitis has not been established. Patients with increased hepatic enzymes during anidulafungin therapy should be monitored for evidence of worsening hepatic function and evaluated for risk/benefit of continuing anidulafungin therapy. Patients with rare hereditary problems of fructose intolerance should not take Ecalta.
Use in pregnancy & lactation: Anidulafungin is not recommended in pregnancy.
It is not known whether anidulafungin is excreted in human breast milk.
Use in children: Ecalta is not recommended for use in children <18 years due to insufficient data on safety and efficacy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in